Goldman Sachs’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $149M | Buy |
|
|||||
|
2025
Q2 | $84.3M | Buy |
|
|||||
|
2025
Q1 | $82.7M | Sell |
|
|||||
|
2024
Q4 | $118M | Sell |
|
|||||
|
2024
Q3 | $192M | Sell |
|
|||||
|
2024
Q2 | $329M | Buy |
|
|||||
|
2024
Q1 | $214M | Sell |
|
|||||
|
2023
Q4 | $284M | Buy |
|
|||||
|
2023
Q3 | $203M | Sell |
|
|||||
|
2023
Q2 | $235M | Buy |
|
|||||
|
2023
Q1 | $184M | Sell |
|
|||||
|
2022
Q4 | $271M | Sell |
|
|||||
|
2022
Q3 | $373M | Sell |
|
|||||
|
2022
Q2 | $335M | Buy |
|
|||||
|
2022
Q1 | $276M | Buy |
|
|||||
|
2021
Q4 | $228M | Buy |
|
|||||
|
2021
Q3 | $226M | Sell |
|
|||||
|
2021
Q2 | $291M | Buy |
|
|||||
|
2021
Q1 | $234M | Buy |
|
|||||
|
2020
Q4 | $134M | Sell |
|
|||||
|
2020
Q3 | $251M | Sell |
|
|||||
|
2020
Q2 | $358M | Buy |
|
|||||
|
2020
Q1 | $404M | Sell |
|
|||||
|
2019
Q4 | $526M | Sell |
|
|||||
|
2019
Q3 | $417M | Buy |
|
|||||
|
2019
Q2 | $419M | Buy |
|
|||||
|
2019
Q1 | $394M | Sell |
|
|||||
|
2018
Q4 | $542M | Sell |
|
|||||
|
2018
Q3 | $800M | Sell |
|
|||||
|
2018
Q2 | $660M | Sell |
|
|||||
|
2018
Q1 | $671M | Buy |
|
|||||
|
2017
Q4 | $731M | Buy |
|
|||||
|
2017
Q3 | $663M | Buy |
|
|||||
|
2017
Q2 | $470M | Sell |
|
|||||
|
2017
Q1 | $475M | Buy |
|
|||||
|
2016
Q4 | $368M | Buy |
|
|||||
|
2016
Q3 | $362M | Buy |
|
|||||
|
2016
Q2 | $274M | Sell |
|
|||||
|
2016
Q1 | $374M | Sell |
|
|||||
|
2015
Q4 | $472M | Sell |
|
|||||
|
2015
Q3 | $496M | Buy |
|
|||||
|
2015
Q2 | $579M | Buy |
|
|||||
|
2015
Q1 | $534M | Sell |
|
|||||
|
2014
Q4 | $612M | Buy |
|
|||||
|
2014
Q3 | $395M | Sell |
|
|||||
|
2014
Q2 | $441M | Buy |
|
|||||
|
2014
Q1 | $378M | Buy |
|
|||||
|
2013
Q4 | $321M | Buy |
|
|||||
|
2013
Q3 | $213M | Sell |
|
|||||
|
2013
Q2 | $225M | Buy |
|